Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Medline Inc. entered into 2033 Refinancing Term Loan Facility with Not specified valued at Refinanced existing senior secured dollar-denominated term loan facility due 2030 with a new senior (effective 2026-05-28).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- Not specified
- Value
- Refinanced existing senior secured dollar-denominated term loan facility due 2030 with a new senior
- Effective
- 2026-05-28
Exact text from the filing
Concurrently with the Notes offering, the Issuer refinanced its existing senior secured dollar-denominated term loan facility due 2030 (the “ 2030 Term Loan Facility ”) with a new senior secured dollar-denominated term loan facility in an aggregate principal amount of approximately $2,750.0 million (the “ 2033 Refinancing Term Loan Facility ” and, together with the existing revolving credit facility, the “ Senior Secured Credit Facilities ”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Medline Inc. entered into Indenture for 5.000% Senior Secured Notes due 2031 and 5.250% Senior Secured Notes due 2033 with Wilmington Trust, National Association valued at Issued $1,250.0 million aggregate principal amount of 5.000% senior secured notes due 2031 and $750. (effective 2026-05-28).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- Wilmington Trust, National Association
- Value
- Issued $1,250.0 million aggregate principal amount of 5.000% senior secured notes due 2031 and $750.
- Effective
- 2026-05-28
Exact text from the filing
On May 28, 2026, Medline Borrower, LP (the “ Issuer ”) and Medline Co-Issuer, Inc. (the “ Co-Issuer ” and, together with the Issuer, the “ Issuers ”), indirect subsidiaries of Medline Inc. (the “ Company ”), issued $1,250.0 million aggregate principal amount of 5.000% senior secured notes due 2031 (the “ 2031 Notes ”) and $750.0 million aggregate principal amount of 5.250% senior secured notes due 2033 (the “ 2033 Notes ” and, together with the 2031 notes, the “ Notes ”), under an Indenture, dated as of May 28, 2026 (the “ Indenture ”), among the Issuers, Medline Intermediate, LP (“ Holdings ”), the direct parent of the Issuer, the subsidiary guarantors party thereto and Wilmington Trust, National Association, as trustee (in such capacity, the “ Trustee ”), paying agent, transfer agent, registrar and notes collateral agent (in such capacity, the “ Notes Collateral Agent ”).
View on SEC.gov